BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant. 2007;7:408-415. [PMID: 17229080 DOI: 10.1111/j.1600-6143.2006.01644.x] [Cited by in Crossref: 259] [Cited by in F6Publishing: 226] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Soulillou J. On the utility of screening for anti-MICA antibodies before kidney transplantation. Nat Rev Nephrol 2008;4:190-1. [DOI: 10.1038/ncpneph0712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Ravindranath MH. HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs. J Immunol Res 2017;2017:3475926. [PMID: 28634589 DOI: 10.1155/2017/3475926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
3 Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W, Chen H, Wang FR, Mo XD, Zhang YY, Huo MR, Zhao XS, Y K, Liu KY, Huang XJ. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 2015;8:84. [PMID: 26156584 DOI: 10.1186/s13045-015-0182-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 13.0] [Reference Citation Analysis]
4 Galvani S, Augé N, Calise D, Thiers JC, Canivet C, Kamar N, Rostaing L, Abbal M, Sallusto F, Salvayre R, Böhler T, Zou Y, Stastny P, Nègre-Salvayre A, Thomsen M. HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant 2009;9:2607-14. [PMID: 19843036 DOI: 10.1111/j.1600-6143.2009.02804.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
5 Cooper JE, Gralla J, Cagle L, Goldberg R, Chan L, Wiseman AC. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes. Transplantation. 2011;91:1103-1109. [PMID: 21403588 DOI: 10.1097/tp.0b013e3182139da1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
6 Sánchez-Zapardiel E, Castro-Panete MJ, Mancebo E, Morales P, Laguna-Goya R, Morales JM, Apaza J, de Andrés A, Talayero P, Paz-Artal E. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity. Nephrol Dial Transplant 2016;31:150-60. [PMID: 26323481 DOI: 10.1093/ndt/gfv308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
7 Cardinal H, Dieudé M, Brassard N, Qi S, Patey N, Soulez M, Beillevaire D, Echeverry F, Daniel C, Durocher Y. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury. Am J Transplant. 2013;13:861-874. [PMID: 23432943 DOI: 10.1111/ajt.12168] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 8.7] [Reference Citation Analysis]
8 Kobayashi T, Katayama A, Kohara S, Nagasaka T, Goto N, Ueki T, Uchida K, Nakao A. Enzyme-Linked Immunosorbent Assay for Human Leukocyte Antigen Antibody Detection and Urine Protein Test Recommended for Follow-Up Monitoring After Renal Transplantation. Transplantation 2008;85:1595-600. [DOI: 10.1097/tp.0b013e318170f79f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Hoshino J, Everly M, Kaneku H, Ubara Y, Takaichi K, Terasaki P. Impact of the Presence and Duration of Donor-Specific Antibodies on Renal Function. Transplantation Proceedings 2014;46:75-80. [DOI: 10.1016/j.transproceed.2013.09.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Narayan S, Tsai EW, Zhang Q, Wallace WD, Reed EF, Ettenger RB. Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient. Pediatr Transplant 2011;15:E1-7. [PMID: 21199204 DOI: 10.1111/j.1399-3046.2010.01407.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
11 Goh A, Oei E, Vathsala A. Successful Transplantation Across Positive B-Cell Cross-Match in Deceased Donor Renal Transplants. Transplantation Proceedings 2012;44:193-9. [DOI: 10.1016/j.transproceed.2011.12.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R. Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies. Am J Transplant. 2014;14:1439-1445. [PMID: 24804568 DOI: 10.1111/ajt.12709] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
13 Everly MJ, Rebellato LM, Haisch CE, Ozawa M, Parker K, Briley KP, Catrou PG, Bolin P, Kendrick WT, Kendrick SA. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation. 2013;95:410-417. [PMID: 23380861 DOI: 10.1097/tp.0b013e31827d62e3] [Cited by in Crossref: 265] [Cited by in F6Publishing: 99] [Article Influence: 29.4] [Reference Citation Analysis]
14 Broeders NE, Hombrouck A, Lemy A, Wissing KM, Racapé J, Gastaldello K, Massart A, Van Gucht S, Weichselbaum L, De Mul A, Brochier B, Thomas I, Abramowicz D. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol 2011;6:2573-8. [PMID: 21921153 DOI: 10.2215/CJN.04670511] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sánchez-Fructuoso AI, Santiago JL, Pérez-Flores I, Calvo Romero N, Valero R. De novo anti-HLA antibodies in renal allograft recipients: a cross-section study. Transplant Proc 2010;42:2874-6. [PMID: 20970556 DOI: 10.1016/j.transproceed.2010.07.079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
16 Wu H, Tien Y, Huang C, Chiang Y, Chu S, Lai P. HLA Class I Antibodies in Patients Awaiting Kidney Transplantation and the Association With Renal Graft Survival. Transplantation Proceedings 2008;40:2191-4. [DOI: 10.1016/j.transproceed.2008.07.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Terasaki PI. The Review by Kwun and Knechtle–“Can it B?”—Asks Whether B Cells Are Responsible for Chronic Rejection of Transplants. Transplantation 2009;88:978-9. [DOI: 10.1097/tp.0b013e3181b998fd] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Melilli E, Crespo E, Sandoval D, Manonelles A, Sala N, Mast R, Padulles A, Grinyo JM, Bestard O, Cruzado JM. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring. Transpl Int 2015;28:1283-90. [DOI: 10.1111/tri.12626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
19 Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S. Incidence and Prediction of Early Antibody-Mediated Rejection due to Non-Human Leukocyte Antigen-Antibodies. Transplantation 2008;85:1557-63. [DOI: 10.1097/tp.0b013e31816f612a] [Cited by in Crossref: 73] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
20 Willicombe M, Brookes P, Sergeant R, Santos-Nunez E, Steggar C, Galliford J, McLean A, Cook TH, Cairns T, Roufosse C, Taube D. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation 2012;94:172-7. [PMID: 22735711 DOI: 10.1097/TP.0b013e3182543950] [Cited by in Crossref: 168] [Cited by in F6Publishing: 48] [Article Influence: 16.8] [Reference Citation Analysis]
21 Lemy A, Andrien M, Wissing KM, Ryhahi K, Vandersarren A, Racapé J, Heylen C, Ghisdal L, Broeders E, Vereerstraeten P, Toungouz M, Abramowicz D. Major Histocompatibility Complex Class 1 Chain-Related Antigen A Antibodies: Sensitizing Events and Impact on Renal Graft Outcomes. Transplantation 2010;90:168-74. [DOI: 10.1097/tp.0b013e3181e228f7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
22 Degauque N, Elong Ngono A, Akl A, Lepetit M, Crochette R, Giral M, Lepourry J, Pallier A, Castagnet S, Dugast E, Guillot-Gueguen C, Jacq-Foucher M, Saulquin X, Cesbron A, Laplaud D, Nicot A, Brouard S, Soulillou JP. Characterization of antigen-specific B cells using nominal antigen-coated flow-beads. PLoS One 2013;8:e84273. [PMID: 24386360 DOI: 10.1371/journal.pone.0084273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Bartel G, Wahrmann M, Exner M, Regele H, Huttary N, Schillinger M, Körmöczi GF, Hörl WH, Böhmig GA. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant. 2008;8:41-49. [PMID: 17924995 DOI: 10.1111/j.1600-6143.2007.01998.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
24 Torres IB, Salcedo M, Moreso F, Sellarés J, Castellá E, Azancot MA, Perelló M, Cantarell C, Serón D. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection. Clin Transplant 2014;28:1148-54. [DOI: 10.1111/ctr.12433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
25 Lee P, Zhu L, Terasaki PI, Everly MJ. HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss. Transplantation 2009;88:568-74. [DOI: 10.1097/tp.0b013e3181b11b72] [Cited by in Crossref: 132] [Cited by in F6Publishing: 38] [Article Influence: 10.2] [Reference Citation Analysis]
26 Marfo K, Lu A, Ling M, Akalin E. Desensitization protocols and their outcome. Clin J Am Soc Nephrol. 2011;6:922-936. [PMID: 21441131 DOI: 10.2215/cjn.08140910] [Cited by in Crossref: 172] [Cited by in F6Publishing: 40] [Article Influence: 15.6] [Reference Citation Analysis]
27 Sumitran-holgersson S. Beyond ABO and human histocompatibility antigen: other histocompatibility antigens with a role in transplantation: . Current Opinion in Organ Transplantation 2008;13:425-9. [DOI: 10.1097/mot.0b013e328307ebd7] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
28 Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47. [PMID: 23238534 DOI: 10.1097/tp.0b013e31827a19cc] [Cited by in Crossref: 525] [Cited by in F6Publishing: 144] [Article Influence: 58.3] [Reference Citation Analysis]
29 Escobedo-Villarreal MM, Mercado-Moreira AB, Muñoz-Espinosa LE, Gamboa-Esparza M, Pérez-Rodríguez E, Cordero-Pérez P. [Urinary protein detection by iTRAQ® associated with renal transplant complications and its modification with therapy]. Cir Cir 2015;83:393-401. [PMID: 26148981 DOI: 10.1016/j.circir.2015.03.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008;86:377-83. [PMID: 18698239 DOI: 10.1097/TP.0b013e31817c4cb8] [Cited by in Crossref: 186] [Cited by in F6Publishing: 59] [Article Influence: 13.3] [Reference Citation Analysis]
31 Alagoz S, Seyahi N. Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation. Transplant Proc 2019;51:2302-7. [PMID: 31358448 DOI: 10.1016/j.transproceed.2019.01.195] [Reference Citation Analysis]
32 Morales-Buenrostro LE, Alberú J. Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation. Transplant Rev (Orlando) 2008;22:27-38. [PMID: 18631856 DOI: 10.1016/j.trre.2007.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
33 Baranwal AK, Bhat DK, Goswami S, Agarwal SK, Kaur G, Mehra N. Clinical relevance of major histocompatibility complex class I chain-related molecule A (MICA) antibodies in live donor renal transplantation - Indian Experience. Scand J Immunol 2020;92:e12923. [PMID: 32593197 DOI: 10.1111/sji.12923] [Reference Citation Analysis]
34 Prigent A, Maillard N, Absi L, Aloui C, Cognasse F, Laradi S, Mariat C, Garraud O. From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization. Antibodies 2014;3:130-52. [DOI: 10.3390/antib3010130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Andolina JR, Walia R, Oliva J, Baran A, Liesveld J, Becker MW, Busacco A, Coppage M. Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients. Hum Immunol 2020;81:407-12. [PMID: 32471661 DOI: 10.1016/j.humimm.2020.05.006] [Reference Citation Analysis]
36 Naji A, Noorchashm H, Cancro MP. New wine in old bottles: expanding roles for B cells in transplantation tolerance. Semin Immunol 2012;24:75-6. [PMID: 22483169 DOI: 10.1016/j.smim.2012.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Ponticelli C, Coppo R, Salvadori M. Glomerular diseases and transplantation: similarities in pathogenetic mechanisms and treatment options. Nephrology Dialysis Transplantation 2010;26:35-41. [DOI: 10.1093/ndt/gfq574] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Suárez-álvarez B, Alonso-arias R, Bravo-mendoza C, López-vázquez A, Ortega T, Baltar JM, Coto E, Ortega F, López-larrea C. Identification of Epitopes and Immunodominant Regions on the MICA Protein Defined by Alloantibodies From Kidney Transplant Patients. Transplantation 2009;88:S68-77. [DOI: 10.1097/tp.0b013e3181afeb7a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
39 Suárez-álvarez B, López-vázquez A, Baltar JM, Ortega F, López-larrea C. Potential Role of NKG2D and Its Ligands in Organ Transplantation: New Target for Immunointervention. American Journal of Transplantation 2009;9:251-7. [DOI: 10.1111/j.1600-6143.2008.02526.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
40 Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Knoll GA. KDIGO Clinical Practice Guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104:S11-S103. [PMID: 32301874 DOI: 10.1097/tp.0000000000003136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 60.0] [Reference Citation Analysis]
41 Amirzargar MA, Amirzargar A, Basiri A, Hajilooi M, Roshanaei G, Rajabi G, Mohammadiazar S, Solgi G. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies. Hum Immunol 2014;75:47-58. [PMID: 24055694 DOI: 10.1016/j.humimm.2013.09.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
42 Nickerson P. Post-transplant monitoring of renal allografts: are we there yet? Curr Opin Immunol 2009;21:563-8. [PMID: 19713093 DOI: 10.1016/j.coi.2009.07.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
43 Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence: Attributing Causes of Kidney Transplant Loss. American Journal of Transplantation 2012;12:388-99. [DOI: 10.1111/j.1600-6143.2011.03840.x] [Cited by in Crossref: 905] [Cited by in F6Publishing: 795] [Article Influence: 82.3] [Reference Citation Analysis]
44 Afzali B, Lechler RI, Hernandez-Fuentes MP. Allorecognition and the alloresponse: clinical implications. Tissue Antigens. 2007;69:545-556. [PMID: 17498264 DOI: 10.1111/j.1399-0039.2007.00834.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
45 Parsons RF, Vivek K, Redfield RR, Migone TS, Cancro MP, Naji A, Noorchashm H. B-cell tolerance in transplantation: is repertoire remodeling the answer? Expert Rev Clin Immunol 2009;5:703. [PMID: 20161663 DOI: 10.1586/eci.09.63] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
46 Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol 2012;24:109-14. [PMID: 21978627 DOI: 10.1016/j.smim.2011.08.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
47 Hamada S, Dumortier J, Thévenin C, Pageaux G, Faure S, Guillaud O, Boillot O, Lachaux A, Luscalov D, Dubois V, Meszaros M. Predictive value of HLAMatchmaker and PIRCHE-II scores for de novo donor-specific antibody formation after adult and pediatric liver transplantation. Transplant Immunology 2020;61:101306. [DOI: 10.1016/j.trim.2020.101306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sánchez-Zapardiel E, Castro-Panete MJ, Castillo-Rama M, Morales P, Lora-Pablos D, Valero-Hervás D, Ruiz-García R, Apaza J, Talayero P, Andrés A. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period. Transplantation. 2013;96:70-78. [PMID: 23624543 DOI: 10.1097/tp.0b013e3182943506] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
49 Frank R, Molina MR, Wald JW, Goldberg LR, Kamoun M, Lal P. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study. J Heart Lung Transplant 2013;32:410-7. [PMID: 23498162 DOI: 10.1016/j.healun.2012.12.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
50 Rangel ÉB, Malheiros DMAC, De Castro MCR, Antunes I, Torres MA, Crescentini F, Genzini T, Perosa M. Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation: Antibody-mediated rejection in pancreas transplantation. Transplant International 2010;23:602-10. [DOI: 10.1111/j.1432-2277.2009.01026.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
51 Basten A. The role of B cells in transplantation and immunopathic diseases. Immune Netw 2010;10:81-4. [PMID: 20631877 DOI: 10.4110/in.2010.10.3.81] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, Metivier F, Randoux C, Kossari N, Guérin A, Geffroy S, Delavaud G, Marin-Esteban V, Glotz D, Charron D, Toubert A. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009;182:1696-705. [PMID: 19155520 DOI: 10.4049/jimmunol.182.3.1696] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
53 Charron D, Suberbielle-boissel C, Al-daccak R. Immunogenicity and Allogenicity: A Challenge of Stem Cell Therapy. J of Cardiovasc Trans Res 2009;2:130-8. [DOI: 10.1007/s12265-008-9062-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
54 Miettinen J, Peräsaari J, Lauronen J, Qvist E, Valta H, Pakarinen M, Merenmies J, Jalanko H. Donor-specific HLA antibodies and graft function in children after renal transplantation. Pediatr Nephrol 2012;27:1011-9. [PMID: 21993970 DOI: 10.1007/s00467-012-2101-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
55 Lionaki S, Panagiotellis K, Iniotaki A, Boletis JN. Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol 2013;2013:849835. [PMID: 24348683 DOI: 10.1155/2013/849835] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
56 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
57 Lu J, Luo L, Guo Y, Long D, Wei L, Shan J, Feng L, Li S, Yang X, Lu Y, Krams S, Li Y. The effect of MICA antigens on transplant outcomes: a systematic review. J Evid Based Med 2011;4:106-21. [PMID: 23672701 DOI: 10.1111/j.1756-5391.2011.01125.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
58 Everly MJ, Everly JJ, Arend LJ, Brailey P, Susskind B, Govil A, Rike A, Roy-chaudhury P, Mogilishetty G, Alloway RR, Tevar A, Woodle ES. Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss. American Journal of Transplantation 2009;9:1063-71. [DOI: 10.1111/j.1600-6143.2009.02577.x] [Cited by in Crossref: 170] [Cited by in F6Publishing: 144] [Article Influence: 13.1] [Reference Citation Analysis]
59 Fichtner A, Süsal C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients. Pediatr Nephrol 2021;36:2473-84. [PMID: 33759004 DOI: 10.1007/s00467-021-04969-1] [Reference Citation Analysis]
60 Viana H, Nolasco F, Santos MC, Carvalho F, Galvão MJ, Santos AR, Bordalo J, Dos Santos JR. Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction. Transplant Proc 2009;41:859-61. [PMID: 19376372 DOI: 10.1016/j.transproceed.2009.02.008] [Reference Citation Analysis]
61 Frank R, Molina MR, Goldberg LR, Wald JW, Kamoun M, Lal P. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy. Am J Clin Pathol 2014;142:809-15. [PMID: 25389335 DOI: 10.1309/AJCPTLBEU5BQ8SHN] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
62 Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009;87:1505-13. [PMID: 19461487 DOI: 10.1097/TP.0b013e3181a44206] [Cited by in Crossref: 268] [Cited by in F6Publishing: 75] [Article Influence: 20.6] [Reference Citation Analysis]
63 Konvalinka A, Tinckam K. Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol. 2015;26:1489-1502. [PMID: 25804279 DOI: 10.1681/asn.2014080837] [Cited by in Crossref: 103] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
64 Parsons RF, Vivek K, Redfield RR 3rd, Migone TS, Cancro MP, Naji A, Noorchashm H. B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) 2010;24:207-21. [PMID: 20655723 DOI: 10.1016/j.trre.2010.05.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
65 Wei X, Yuan X, Sun M, Pan Z, Hu L, Wang L, He J, Hou J. Association of C1q Binding Status With De Novo HLA Antibody Clinical Features and Allograft Function in Kidney Transplantation Patients During Eight Years of Dynamic Follow-up. Transplant Proc 2016;48:1944-54. [PMID: 27569927 DOI: 10.1016/j.transproceed.2016.05.010] [Reference Citation Analysis]
66 Reinsmoen NL. Immunological Risk Stratification by Assessing Both the HLA and Non-HLA-Specific Antibodies: Time to Include Testing for Non-HLA Antibodies in the Routine Clinical Antibody Analysis Profile? Transplantation 2017;101:23-5. [DOI: 10.1097/tp.0000000000001495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
67 Parajuli S, Joachim E, Alagusundaramoorthy S, Blazel J, Aziz F, Garg N, Muth B, Mohamed M, Mandelbrot D, Zhong W, Djamali A. Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes. Transplantation 2019;103:1722-9. [DOI: 10.1097/tp.0000000000002566] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
68 Carapito R, Bahram S. Genetics, genomics, and evolutionary biology of NKG2D ligands. Immunol Rev 2015;267:88-116. [PMID: 26284473 DOI: 10.1111/imr.12328] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 12.7] [Reference Citation Analysis]
69 Reinsmoen NL, Cornett KM, Kloehn R, Burnette AD, McHugh L, Flewellen BK, Matas A, Savik K. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation 2008;85:462-70. [PMID: 18301338 DOI: 10.1097/TP.0b013e3181612ead] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
70 Benseffaj N, Ouadghiri S, Bourhanbour AD, Zerrouki AN, Essakalli M. [Cytotoxicity of natural anti-HLA antibodies in Moroccan patients awaiting for kidney transplantation]. Nephrol Ther 2017;13:26-9. [PMID: 27914916 DOI: 10.1016/j.nephro.2016.07.449] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Pearl MH, Nayak AB, Ettenger RB, Puliyanda D, Palma Diaz MF, Zhang Q, Reed EF, Tsai EW. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection. Pediatr Nephrol 2016;31:1341-8. [PMID: 27048228 DOI: 10.1007/s00467-016-3319-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
72 Tan HP, Donaldson J, Basu A, Unruh M, Randhawa P, Sharma V, Morgan C, McCauley J, Wu C, Shah N. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant. 2009;9:355-366. [PMID: 19120078 DOI: 10.1111/j.1600-6143.2008.02492.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
73 Breman E, Ruben JM, Franken KL, Heemskerk MH, Roelen DL, Claas FH, van Kooten C. Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition. J Immunol Res 2016;2016:4215684. [PMID: 27413760 DOI: 10.1155/2016/4215684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Waiser J, Budde K, Schütz M, Liefeldt L, Rudolph B, Schönemann C, Neumayer HH, Lachmann N. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection. Nephrol Dial Transplant. 2012;27:1246-1251. [PMID: 21852274 DOI: 10.1093/ndt/gfr465] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
75 Shipkova M. Biomarker monitoring in immunosuppressant therapy. Personalized Immunosuppression in Transplantation. Elsevier; 2016. pp. 125-52. [DOI: 10.1016/b978-0-12-800885-0.00006-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Geneugelijk K, Spierings E. Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes. Int J Immunogenet 2018;45:41-53. [PMID: 29464898 DOI: 10.1111/iji.12359] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
77 Duff CE, Simmonds MJ. Genetic predictors of long-term graft function in kidney and pancreas transplant patients. Brief Funct Genomics 2017;16:228-37. [PMID: 28110269 DOI: 10.1093/bfgp/elw039] [Reference Citation Analysis]
78 Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Burton H, Douthwaite H, Wilkinson H, Semik V, Dodd PC, Brookes P, Lechler RI, Hernandez-Fuentes MP, Kemper C, Dorling A. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. Kidney Int 2017;91:477-92. [PMID: 27988211 DOI: 10.1016/j.kint.2016.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
79 Najafian B, Kasiske BL. Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 2008;17:149-55. [PMID: 18277147 DOI: 10.1097/MNH.0b013e3282f4e514] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
80 Glotz D. Intérêt du monitoring du rejet aigu médié par anticorps post-transplantation ? Néphrologie & Thérapeutique 2008;4:S8-S12. [DOI: 10.1016/s1769-7255(08)73645-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
81 Duquesnoy RJ, Mostecki J, Marrari M, da Silva AS, da Mata Sousa LCD, do Monte SJH. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry. Int J Immunogenet 2014;41:370-7. [DOI: 10.1111/iji.12137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
82 Luo L, Lu J, Wei L, Long D, Guo JY, Shan J, Li FS, Lu PY, Li PY, Feng L. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010;11:91. [PMID: 21092233 DOI: 10.1186/1471-2121-11-91] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
83 Mulley WR, Kanellis J. Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist: Understanding crossmatching. Nephrology 2011;16:125-33. [DOI: 10.1111/j.1440-1797.2010.01414.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
84 Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation. 2008;86:1019-1025. [PMID: 18946337 DOI: 10.1097/tp.0b013e3181889748] [Cited by in Crossref: 51] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
85 Filippone EJ, Farber JL. Humoral Immune Response and Allograft Function in Kidney Transplantation. Am J Kidney Dis 2015;66:337-47. [PMID: 25987262 DOI: 10.1053/j.ajkd.2015.03.033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
86 Townamchai N, Safa K, Chandraker A. Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract 2013;32:52-61. [PMID: 26877913 DOI: 10.1016/j.krcp.2013.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
87 Banasik M, Kościelska-Kasprzak K, Myszka M, Bartoszek D, Zabińska M, Boratyńska M, Kamińska D, Mazanowska O, Zmonarski S, Krajewska M, Hałoń A, Dawiskiba T, Nowakowska B, Klinger M. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population. Transplant Proc 2014;46:2613-7. [PMID: 25380878 DOI: 10.1016/j.transproceed.2014.09.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Szatmary P, Jones J, Hammad A, Middleton D. Impact of sensitivity of human leucocyte antigen antibody detection by Luminex technology on graft loss at 1 year. Clin Kidney J 2013;6:283-6. [PMID: 26064487 DOI: 10.1093/ckj/sft037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
89 Michielsen LA, van Zuilen AD, Krebber MM, Verhaar MC, Otten HG. Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma? Transplantation Reviews 2016;30:195-202. [DOI: 10.1016/j.trre.2016.06.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
90 Alheim M, AlMahri A, Nilsson J, Tydén G, Holgersson J. The outcome of the endothelial precursor cell crossmatch test in lymphocyte crossmatch positive and negative patients evaluated for living donor kidney transplantation. Hum Immunol 2013;74:1437-44. [PMID: 23777925 DOI: 10.1016/j.humimm.2013.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
91 Davis S, Cooper JE. Acute antibody-mediated rejection in kidney transplant recipients. Transplantation Reviews 2017;31:47-54. [DOI: 10.1016/j.trre.2016.10.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
92 Ma J, Patel A, Tinckam K. Donor-Specific Antibody Monitoring: Where Is the Beef? Adv Chronic Kidney Dis 2016;23:317-25. [PMID: 27742387 DOI: 10.1053/j.ackd.2016.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Walsh RC, Alloway RR, Girnita AL, Woodle ES. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int. 2012;81:1067-1074. [PMID: 22336990 DOI: 10.1038/ki.2011.502] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
94 Li L, Chen A, Chaudhuri A, Kambham N, Sigdel T, Chen R, Sarwal MM. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010;89:312-9. [PMID: 20145522 DOI: 10.1097/TP.0b013e3181bbbe4c] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
95 Tonnerre P, Gérard N, Chatelais M, Charreau B. MICA gene polymorphism in kidney allografts and possible impact of functionally relevant variants. Transplant Proc. 2010;42:4318-4321. [PMID: 21168690 DOI: 10.1016/j.transproceed.2010.09.118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
96 Parajuli S, Joachim E, Alagusundaramoorthy S, Aziz F, Blazel J, Garg N, Muth B, Mohamed M, Redfield RR, Mandelbrot DA, Zhong W, Djamali A. Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure. Kidney Int Rep 2019;4:1057-65. [PMID: 31440696 DOI: 10.1016/j.ekir.2019.04.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
97 Iacob S, Cicinnati VR, Dechêne A, Lindemann M, Heinemann FM, Rebmann V, Ferencik S, Sotiropoulos GC, Popescu I, Horn PA, Gerken G, Paul A, Beckebaum S. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int 2012;32:1253-61. [PMID: 22550960 DOI: 10.1111/j.1478-3231.2012.02810.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
98 Ye J, Li J, Zhou M, Xia R, Liu R, Yu L. Modulation of Donor-Specific Antibody Production After Organ Transplantation by Valproic Acid: A Histone Deacetylase Inhibitor. Transplantation 2016;100:2342-51. [PMID: 27140514 DOI: 10.1097/TP.0000000000001197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
99 Choy M, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends in Molecular Medicine 2010;16:97-106. [DOI: 10.1016/j.molmed.2010.01.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
100 Leffell MS, Zachary AA. Antiallograft antibodies: relevance, detection, and monitoring: . Current Opinion in Organ Transplantation 2010;15:2-7. [DOI: 10.1097/mot.0b013e3283342798] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
101 Athavale D, Worthington J, Webb NJ, Roberts D, Martin S, Shenoy M. Pediatric kidney recipients may benefit from monitoring for donor-specific antibodies. Pediatr Transplant 2014;18:258-65. [PMID: 24646402 DOI: 10.1111/petr.12247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
102 Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Semik V, Cook HT, Roufosse C, Brookes P, Bowers RW, Galliford J. B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection. Kidney Int. 2015;88:560-568. [PMID: 25830760 DOI: 10.1038/ki.2015.100] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
103 Zachary AA, Leffell MS. Detecting and monitoring human leukocyte antigen-specific antibodies. Hum Immunol. 2008;69:591-604. [PMID: 18692106 DOI: 10.1016/j.humimm.2008.06.013] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
104 Dias AL, Hashmi S, Hogan W, Baig N, Wakefield L, Kreuter J, Gandhi MJ. The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection. Bone Marrow Transplant 2017;52:902-4. [DOI: 10.1038/bmt.2017.13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
105 Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol 2015; 21(39): 11016-11026 [PMID: 26494958 DOI: 10.3748/wjg.v21.i39.11016] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
106 Delville M, Charreau B, Rabant M, Legendre C, Anglicheau D. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand? Hum Immunol 2016;77:1055-62. [PMID: 27237040 DOI: 10.1016/j.humimm.2016.05.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
107 Nabokow A, Dobronravov VA, Khrabrova M, Gröne H, Gröne E, Hallensleben M, Kieneke D, Weithofer P, Smirnov AV, Kliem V. Long-Term Kidney Allograft Survival in Patients With Transplant Glomerulitis. Transplantation 2015;99:331-9. [DOI: 10.1097/tp.0000000000000606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Jeon JH, Baek IC, Hong CH, Park KH, Lee H, Oh EJ, Kim TG. Establishment of HLA class I and MICA/B null HEK-293T panel expressing single MICA alleles to detect anti-MICA antibodies. Sci Rep 2021;11:15716. [PMID: 34344955 DOI: 10.1038/s41598-021-95058-8] [Reference Citation Analysis]
109 Levitsky J, Kaneku H, Jie C, Walsh RC, Abecassis M, Tambur AR. Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients. Am J Transplant 2016;16:2437-44. [PMID: 26896194 DOI: 10.1111/ajt.13757] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
110 Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C. Intact HLA Not β2m-free Heavy Chain-Specific HLA Class I Antibodies Are Predictive of Graft Failure. Transplantation 2009;88:226-30. [DOI: 10.1097/tp.0b013e3181ac6198] [Cited by in Crossref: 72] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
111 Su H, Zhang CY, Lin JH, Hammes HP, Zhang C. The Role of Long-Lived Plasma Cells in Antibody-Mediated Rejection of Kidney Transplantation: An Update. Kidney Dis (Basel) 2019;5:211-9. [PMID: 31768378 DOI: 10.1159/000501460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Mehra NK, Siddiqui J, Baranwal A, Goswami S, Kaur G. Clinical relevance of antibody development in renal transplantation. Ann N Y Acad Sci. 2013;1283:30-42. [PMID: 23384346 DOI: 10.1111/nyas.12034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
113 Regele H. Die Rolle von Endothelzellen in der Transplantatabstoßung. Pathologe 2008;29:141-4. [DOI: 10.1007/s00292-008-1077-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
114 Baranwal AK, Mehra NK. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation. Front Immunol 2017;8:182. [PMID: 28293239 DOI: 10.3389/fimmu.2017.00182] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
115 Schinstock CA, Gandhi MJ, Stegall MD. Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation 2016;100:1619-28. [PMID: 27140516 DOI: 10.1097/TP.0000000000001203] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
116 Reinsmoen NL. Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies. Hum Immunol 2019;80:555-60. [PMID: 31279533 DOI: 10.1016/j.humimm.2019.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
117 Salvadori M, Bertoni E. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant 2014; 4(1): 1-17 [PMID: 24669363 DOI: 10.5500/wjt.v4.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
118 Roedder S, Vitalone M, Khatri P, Sarwal MM. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 2011;3:37. [PMID: 21658299 DOI: 10.1186/gm253] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
119 Bucşa C, Ştefan G, Tacu D, Sinescu I, Sinescu RD, Hârza M. Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure? Int Urol Nephrol 2014;46:1857-65. [DOI: 10.1007/s11255-014-0761-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
120 Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient. Nephrology (Carlton) 2015;20 Suppl 2:81-5. [PMID: 26031594 DOI: 10.1111/nep.12453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
121 Heinold A, Kuehl B, Brenner-Weiss G, Opelz G, Tran TH. Sequential analysis by immunoprecipitation-MALDI-TOF: a novel method for detection and identification of alloantibody specificities. Hum Immunol 2010;71:462-7. [PMID: 20149830 DOI: 10.1016/j.humimm.2010.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
122 Yoshihara S, Taniguchi K, Ogawa H, Saji H. The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA? Bone Marrow Transplant 2012;47:1499-506. [PMID: 22231464 DOI: 10.1038/bmt.2011.249] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
123 Shan J, Feng L, Luo L, Wu W, Li C, Li S, Li Y. MicroRNAs: potential biomarker in organ transplantation. Transpl Immunol 2011;24:210-5. [PMID: 21459143 DOI: 10.1016/j.trim.2011.03.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
124 Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations. Transpl Int 2014;27:60-8. [PMID: 24131087 DOI: 10.1111/tri.12207] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
125 Baranwal AK, Bhat DK, Goswami S, Agarwal SK, Kaur G, Kaur J, Mehra N. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation. Indian J Med Res 2017;145:222-8. [PMID: 28639599 DOI: 10.4103/ijmr.IJMR_222_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
126 Zachary AA, Leffell MS. Barriers to successful transplantation of the sensitized patient. Expert Review of Clinical Immunology 2014;6:449-60. [DOI: 10.1586/eci.10.14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
127 López-Vázquez A, Mozo L, Alonso-Arias R, Suárez-Álvarez B, Vidal-Castiñeira JR, Arranz E, Volta U, Bousoño C, López-Hoyos M, Rodrigo L, López-Larrea C. Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients. BMC Med 2014;12:34. [PMID: 24565339 DOI: 10.1186/1741-7015-12-34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Beyzaei Z, Geramizadeh B, Bagheri Z, Karimzadeh S, Shojazadeh A. De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis. Front Immunol 2020;11:613128. [PMID: 33424868 DOI: 10.3389/fimmu.2020.613128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Piotti G, Palmisano A, Maggiore U, Buzio C. Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol. 2014;5:505. [PMID: 25374567 DOI: 10.3389/fimmu.2014.00505] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
130 Claas FH. Clinical relevance of circulating donor-specific HLA antibodies. Curr Opin Organ Transplant 2010;15:462-6. [PMID: 20613523 DOI: 10.1097/MOT.0b013e32833b9c38] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
131 Varma PP, Hooda AK, Kumar A, Singh L. Highly successful and low-cost desensitization regime for sensitized living donor renal transplant recipients. Ren Fail 2009;31:533-7. [PMID: 19839846 DOI: 10.1080/08860220903001861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
132 Hönger G, Mayr M, Dickenmann M, Mihatsch MJ, Schaub S. Urinary C4d Does Not Correlate With C4d-Staining in Peritubular Capillaries But Reflects Nonspecific Glomerular Injury. Transplantation 2008;85:542-6. [DOI: 10.1097/tp.0b013e3181641d8c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
133 Delgado JC, Eckels DD. Positive B-cell only flow cytometric crossmatch: Implications for renal transplantation. Experimental and Molecular Pathology 2008;85:59-63. [DOI: 10.1016/j.yexmp.2008.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
134 Zou Y, Stastny P. Screening for Antibodies Against MICA by Luminex Flow Cytometry. In: Christiansen FT, Tait BD, editors. Immunogenetics. Totowa: Humana Press; 2012. pp. 279-88. [DOI: 10.1007/978-1-61779-842-9_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
135 Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Transpl Int 2017;30:277-87. [PMID: 27992962 DOI: 10.1111/tri.12905] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
136 Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12:1157-1167. [PMID: 22429309 DOI: 10.1111/j.1600-6143.2012.04013.x] [Cited by in Crossref: 649] [Cited by in F6Publishing: 583] [Article Influence: 64.9] [Reference Citation Analysis]
137 Grenzi PC, Campos ÉF, Tedesco-Silva H, Felipe CR, Franco MF, Soares MF, Medina-Pestana JO, Gerbase-Delima M. Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. Transpl Immunol 2013;29:34-8. [PMID: 23928467 DOI: 10.1016/j.trim.2013.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
138 Campbell PM, Senior PA, Salam A, Labranche K, Bigam DL, Kneteman NM, Imes S, Halpin A, Ryan EA, Shapiro AM. High risk of sensitization after failed islet transplantation. Am J Transplant. 2007;7:2311-2317. [PMID: 17845564 DOI: 10.1111/j.1600-6143.2007.01923.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 101] [Article Influence: 8.4] [Reference Citation Analysis]
139 Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A. Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial. Transpl Int 2019;32:614-25. [DOI: 10.1111/tri.13412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
140 Wiebe C, Nickerson P. Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation. Curr Opin Organ Transplant 2013;18:470-7. [PMID: 23695596 DOI: 10.1097/MOT.0b013e3283626149] [Cited by in Crossref: 54] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
141 Kaneku H, O'Leary JG, Banuelos N, Jennings LW, Susskind BM, Klintmalm GB, Terasaki PI. De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant. 2013;13:1541-1548. [PMID: 23721554 DOI: 10.1002/ajt.12212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 56] [Article Influence: 0.7] [Reference Citation Analysis]
142 Zhang X, Reinsmoen NL. Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation. Front Immunol 2017;8:434. [PMID: 28450866 DOI: 10.3389/fimmu.2017.00434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
143 Arias M, Rush DN, Wiebe C, Gibson IW, Blydt-Hansen TD, Nickerson PW, Sellarés J, López-Hoyos M, San Segundo D, Crespo-Leiro MG, Marzoa-Rivas R, Barge-Caballero E, Paniagua-Martín MJ, Román A, Serón D, Böhmig G, Schwaiger E. Antibody-mediated rejection: analyzing the risk, proposing solutions. Transplantation 2014;98 Suppl 3:S3-21. [PMID: 25093441 DOI: 10.1097/TP.0000000000000218] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
144 Tan HP, Donaldson J, Ellis D, Moritz ML, Basu A, Morgan C, Vats AN, Erkan E, Shapiro R. Pediatric Living Donor Kidney Transplantation Under Alemtuzumab Pretreatment and Tacrolimus Monotherapy: 4-Year Experience. Transplantation 2008;86:1725-31. [DOI: 10.1097/tp.0b013e3181903da7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
145 Wang S, Zhang C, Wang J, Yang C, Xu M, Rong R, Zhu T, Zhu D. Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. J Immunol Res 2017;2017:8746303. [PMID: 28255564 DOI: 10.1155/2017/8746303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
146 Chauveau A, Tonnerre P, Pabois A, Gavlovsky PJ, Chatelais M, Coupel S, Charreau B. Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding. J Innate Immun 2014;6:89-104. [PMID: 23860405 DOI: 10.1159/000351605] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
147 Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS, Eckels DD. No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation. 2009;87:546-548. [PMID: 19307792 DOI: 10.1097/tp.0b013e3181949d2e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
148 Akiyoshi T, Hirohashi T, Alessandrini A, Chase CM, Farkash EA, Neal Smith R, Madsen JC, Russell PS, Colvin RB. Role of complement and NK cells in antibody mediated rejection. Hum Immunol. 2012;73:1226-1232. [PMID: 22850181 DOI: 10.1016/j.humimm.2012.07.330] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
149 Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl 2014;20:514-27. [PMID: 24470340 DOI: 10.1002/lt.23826] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
150 Todeschini M, Cortinovis M, Perico N, Poli F, Innocente A, Cavinato RA, Gotti E, Ruggenenti P, Gaspari F, Noris M, Remuzzi G, Casiraghi F. In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development. J I 2013;191:2818-28. [DOI: 10.4049/jimmunol.1203261] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
151 Halloran PF, Bromberg J, Kaplan B, Vincenti F. Tolerance versus immunosuppression: a perspective. Am J Transplant 2008;8:1365-6. [PMID: 18557737 DOI: 10.1111/j.1600-6143.2008.02289.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
152 Li L, Wadia P, Chen R, Kambham N, Naesens M, Sigdel TK, Miklos DB, Sarwal MM, Butte AJ. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A 2009;106:4148-53. [PMID: 19251643 DOI: 10.1073/pnas.0900563106] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 6.5] [Reference Citation Analysis]
153 Pearl MH, Chen L, ElChaki R, Elashoff D, Gjertson DW, Rossetti M, Weng PL, Zhang Q, Reed EF, Chambers ET. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation. Kidney Int Rep 2020;5:1925-36. [PMID: 33163713 DOI: 10.1016/j.ekir.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
154 Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Tsai Chambers E. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. Kidney Int 2018;93:260-9. [PMID: 28927645 DOI: 10.1016/j.kint.2017.06.034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
155 Lo DJ, Kaplan B, Kirk AD. Biomarkers for kidney transplant rejection. Nat Rev Nephrol. 2014;10:215-225. [PMID: 24445740 DOI: 10.1038/nrneph.2013.281] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
156 Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G; Collaborative Transplant Study Report. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation 2015;99:1976-80. [PMID: 25769065 DOI: 10.1097/TP.0000000000000672] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 6.9] [Reference Citation Analysis]
157 Gates KV, Pereira NL, Griffiths LG. Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles. Front Immunol 2017;8:1332. [PMID: 29093713 DOI: 10.3389/fimmu.2017.01332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
158 Gaston RS. Our evolving understanding of late kidney allograft failure. Curr Opin Organ Transplant 2011;16:594-9. [PMID: 21971511 DOI: 10.1097/MOT.0b013e32834c23a7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
159 Wissing KM, Abramowicz D. Unacceptable human leucocyte antigens: how to navigate between increased immunological risk and waiting time? Nephrol Dial Transplant 2017;32:745-7. [PMID: 28371874 DOI: 10.1093/ndt/gfx028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
160 Zhang Q, Cecka JM, Gjertson DW, Ge P, Rose ML, Patel JK, Ardehali A, Kobashigawa JA, Fishbein MC, Reed EF. HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation. 2011;91:1153-1158. [PMID: 21544036 DOI: 10.1097/tp.0b013e3182157d60] [Cited by in Crossref: 82] [Cited by in F6Publishing: 34] [Article Influence: 7.5] [Reference Citation Analysis]
161 Arias M, Serón D, Moreso F, Bestard O, Praga M. Chronic renal allograft damage: existing challenges. Transplantation 2011;91:S4-25. [PMID: 21519213 DOI: 10.1097/TP.0b013e31821792fd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
162 Luo L, Li Z, Wu W, Luo G, Mei H, Sun Z, Xu C. The effect of MICA antigens on kidney transplantation outcomes. Immunol Lett 2013;156:54-8. [PMID: 24004718 DOI: 10.1016/j.imlet.2013.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
163 Hassan S, Regan F, Brown C, Harmer A, Anderson N, Beckwith H, Roufosse CA, Santos-Nunez E, Brookes P, Taube D, Willicombe M. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation. Am J Transplant 2019;19:1720-9. [PMID: 30582278 DOI: 10.1111/ajt.15233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
164 Furuya M, Yamamoto I, Kobayashi A, Nakada Y, Sugano N, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoyama K, Yokoo T. Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation: Plasma cell-rich rejection. Nephrology 2014;19:31-4. [DOI: 10.1111/nep.12245] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
165 Kongkaew S, Yotmanee P, Rungrotmongkol T, Kaiyawet N, Meeprasert A, Kaburaki T, Noguchi H, Takeuchi F, Kungwan N, Hannongbua S. Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's Disease. PLoS One 2015;10:e0135575. [PMID: 26331842 DOI: 10.1371/journal.pone.0135575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
166 Matignon M, Pilon C, Commereuc M, Grondin C, Leibler C, Kofman T, Audard V, Cohen J, Canoui-Poitrine F, Grimbert P. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study. PLoS One 2017;12:e0178572. [PMID: 28654684 DOI: 10.1371/journal.pone.0178572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
167 Suárez-Álvarez B, Fernández-Sánchez A, López-Vázquez A, Coto E, Ortega F, López-Larrea C. NKG2D and its ligands: active factors in the outcome of solid organ transplantation? Kidney Int Suppl (2011) 2011;1:52-7. [PMID: 25018903 DOI: 10.1038/kisup.2011.13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
168 Kaneku H, O'Leary JG, Banuelos N, Jennings LW, Susskind BM, Klintmalm GB, Terasaki PI. De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant 2013;13:1541-8. [PMID: 23721554 DOI: 10.1002/ajt.12212] [Cited by in Crossref: 175] [Cited by in F6Publishing: 108] [Article Influence: 19.4] [Reference Citation Analysis]
169 Girnita AL, Girnita DM, Zeevi A. Role of anti-HLA antibodies in allograft rejection. Current Opinion in Organ Transplantation 2007;12:420-5. [DOI: 10.1097/mot.0b013e32825a6a44] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
170 Hirohashi T, Uehara S, Chase CM, DellaPelle P, Madsen JC, Russell PS, Colvin RB. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010;10:510-7. [PMID: 20055805 DOI: 10.1111/j.1600-6143.2009.02958.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
171 Mahendra A, Peyron I, Dollinger C, Gilardin L, Sharma M, Wootla B, Padiolleau-Lefevre S, Friboulet A, Boquet D, Legendre C, Kaveri SV, Thaunat O, Lacroix-Desmazes S. IVIg treatment reduces catalytic antibody titers of renal transplanted patients. PLoS One 2013;8:e70731. [PMID: 23967092 DOI: 10.1371/journal.pone.0070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
172 Davis S, Gralla J, Klem P, Stites E, Wiseman A, Cooper JE. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor–Specific Antibodies. Transplantation 2020;104:881-7. [DOI: 10.1097/tp.0000000000002913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
173 Wong W, DeVito J, Nguyen H, Sarracino D, Porcheray F, Dargon I, Pelle PD, Collins AB, Tolkoff-Rubin N, Smith RN, Colvin R, Zorn E. Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine. Am J Transplant 2010;10:2463-71. [PMID: 20977637 DOI: 10.1111/j.1600-6143.2010.03290.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
174 Gloor JM. The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric kidney transplant recipients. Pediatr Transplant 2011;15:557-63. [PMID: 21199216 DOI: 10.1111/j.1399-3046.2010.01455.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Cai J, Qing X, Tan J, Terasaki PI. Humoral theory of transplantation: some hot topics. British Medical Bulletin 2013;105:139-55. [DOI: 10.1093/bmb/lds037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
176 Mehra NK, Baranwal AK. Clinical and immunological relevance of antibodies in solid organ transplantation. Int J Immunogenet 2016;43:351-68. [DOI: 10.1111/iji.12294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
177 Schinstock CA, Stegall M, Cosio F. New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy. Curr Opin Nephrol Hypertens. 2014;23:611-618. [PMID: 25295960 DOI: 10.1097/mnh.0000000000000070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
178 Aubert O, Suberbielle C, Gauthe R, Francois H, Obada EN, Durrbach A. Effect of a Proteasome Inhibitor Plus Steroids on HLA Antibodies in Sensitized Patients Awaiting a Renal Transplant. Transplantation 2014;97:946-52. [DOI: 10.1097/01.tp.0000438207.42465.40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
179 Smith RN, Colvin RB. Chronic alloantibody mediated rejection. Semin Immunol. 2012;24:115-121. [PMID: 22051115 DOI: 10.1016/j.smim.2011.09.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
180 Colvin RB, Hirohashi T, Farris AB, Minnei F, Collins AB, Smith RN. Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl 2010;:S13-7. [PMID: 21116310 DOI: 10.1038/ki.2010.436] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
181 Chowdhry M, Makroo RN, Singh M, Kumar M, Thakur Y, Sharma V. Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India. J Immunol Res 2018;2018:3434050. [PMID: 29850626 DOI: 10.1155/2018/3434050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 Cox ST, Stephens HA, Fernando R, Karasu A, Harber M, Howie AJ, Powis S, Zou Y, Stastny P, Madrigal JA, Little AM. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol 2011;72:827-34. [PMID: 21664940 DOI: 10.1016/j.humimm.2011.05.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
183 Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: Anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Transplant Immunology 2012;26:81-7. [DOI: 10.1016/j.trim.2011.12.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
184 Reindl-schwaighofer R, Heinzel A, Signorini L, Thaunat O, Oberbauer R. Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses. Transpl Int 2018;31:239-50. [DOI: 10.1111/tri.13059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
185 Luo L, Li Z, Wu W, Luo G, Xu C, Sun Z, Mei H. Role of MICA antibodies in solid organ transplantation. Clin Transplant 2014;28:152-60. [DOI: 10.1111/ctr.12295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
186 Breimer ME, Rydberg L, Jackson AM, Lucas DP, Zachary AA, Melancon JK, Von Visger J, Pelletier R, Saidman SL, Williams WW. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation. 2009;87:549-556. [PMID: 19307793 DOI: 10.1097/tp.0b013e3181949d4e] [Cited by in Crossref: 89] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
187 Strommen AM, Moss MC, Goebel J, Bock M. Donor‐specific antibodies in a pediatric kidney transplant population—Prevalence and association with antiproliferative drug dosing. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
188 Alberu J, Vargas-Rojas MI, Morales-Buenrostro LE, Crispin JC, Rodríguez-Romo R, Uribe-Uribe NO, Carrasco G, Gómez-Martín D, Alcocer-Varela J. De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction? J Transplant 2012;2012:302539. [PMID: 22970343 DOI: 10.1155/2012/302539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
189 Cioni M, Comoli P, Tagliamacco A, Innocente A, Basso S, Fontana I, Magnasco A, Trivelli A, Nocco A, Macchiagodena M, Catenacci L, Klersy C, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Nocera A. Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation. Transpl Immunol 2021;65:101375. [PMID: 33610675 DOI: 10.1016/j.trim.2021.101375] [Reference Citation Analysis]
190 Morales-Buenrostro LE, Castro R, Terasaki PI. A single human leukocyte antigen-antibody test after heart or lung transplantation is predictive of survival. Transplantation 2008;85:478-81. [PMID: 18301340 DOI: 10.1097/TP.0b013e3181605cd9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
191 Dieplinger G, Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Harland RC, Terasaki PI. Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction. Transplantation 2014;98:1097-104. [DOI: 10.1097/tp.0000000000000190] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
192 Dorling A, Rebollo-Mesa I, Hilton R, Peacock JL, Vaughan R, Gardner L, Danzi G, Baker R, Clark B, Thuraisingham RC. Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial. Trials. 2014;15:30. [PMID: 24447519 DOI: 10.1186/1745-6215-15-30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
193 Duquesnoy RJ, Mostecki J, Hariharan J, Balazs I. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns. Hum Immunol 2008;69:826-32. [PMID: 18957310 DOI: 10.1016/j.humimm.2008.10.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
194 Uzunel M, Kasimu H, Joshi M, Ge X, Liu J, Xu B, Jaksch M, Jorns C, Nowak G, Sumitran-holgersson S. Evidence for no relevance of anti-major histocompatibility complex class i-related chain a antibodies in liver transplantation: Mica in Liver. Liver Transpl 2008;14:1793-802. [DOI: 10.1002/lt.21620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
195 Salinas GF, Braza F, Brouard S, Tak PP, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol 2013;146:34-45. [PMID: 23202542 DOI: 10.1016/j.clim.2012.10.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
196 de Souza PS, David-neto E, Panajotopolous N, Agena F, Rodrigues H, Ronda C, David DR, Kalil J, Nahas WC, de Castro MCR. Dynamics of anti-human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome. Clin Transplant 2014;28:1234-43. [DOI: 10.1111/ctr.12451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
197 Lemy A, Andrien M, Lionet A, Labalette M, Noel C, Hiesse C, Delahousse M, Suberbielle-Boissel C, De Meyer M, Latinne D, Mourad M, Delsaut S, Racapé J, Wissing KM, Toungouz M, Abramowicz D. Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients. Transplantation 2012;93:1258-64. [PMID: 22466790 DOI: 10.1097/TP.0b013e31824fd8f1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
198 Cravedi P, Heeger PS. Immunologic monitoring in transplantation revisited. Curr Opin Organ Transplant. 2012;17:26-32. [PMID: 22186089 DOI: 10.1097/mot.0b013e32834ee402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
199 Lemy A, Toungouz M, Abramowicz D. Bortezomib: a new player in pre- and post-transplant desensitization? Nephrol Dial Transplant. 2010;25:3480-3489. [PMID: 20826741 DOI: 10.1093/ndt/gfq502] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
200 Vimal M, Chacko MP, Basu G, Daniel D. Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients. Indian J Nephrol 2017;27:347-52. [PMID: 28904429 DOI: 10.4103/ijn.IJN_132_16] [Reference Citation Analysis]
201 Thaunat O. Humoral immunity in chronic allograft rejection: Puzzle pieces come together. Transplant Immunology 2012;26:101-6. [DOI: 10.1016/j.trim.2011.11.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
202 Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, González Escribano F, Olivas I, Torre-Cisneros J, Gavaldá J, Aydillo T, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Roca C, Lara R, Pérez-Romero P. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. Front Immunol 2020;11:1917. [PMID: 33123119 DOI: 10.3389/fimmu.2020.01917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
203 Ginevri F, Nocera A, Comoli P, Innocente A, Cioni M, Parodi A, Fontana I, Magnasco A, Nocco A, Tagliamacco A, Sementa A, Ceriolo P, Ghio L, Zecca M, Cardillo M, Garibotto G, Ghiggeri GM, Poli F. Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection: Impact of De Novo DSA in Pediatric Kidney Recipients . American Journal of Transplantation 2012;12:3355-62. [DOI: 10.1111/j.1600-6143.2012.04251.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 11.3] [Reference Citation Analysis]
204 Zou Y, Stastny P. The role of major histocompatibility complex class I chain-related gene A antibodies in organ transplantation. Curr Opin Organ Transplant 2009;14:414-8. [PMID: 19610173 DOI: 10.1097/mot.0b013e32832d835e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
205 Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Michallet M. Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens. Exp Hematol 2012;40:792-9. [PMID: 22705505 DOI: 10.1016/j.exphem.2012.06.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
206 Sumitran-Holgersson S. Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol. 2008;20:607-613. [PMID: 18675346 DOI: 10.1016/j.coi.2008.07.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
207 Wenda S, Faé I, Sanchez-Mazas A, Nunes JM, Mayr WR, Fischer GF. The distribution of MICA alleles in an Austrian population: evidence for increasing polymorphism. Hum Immunol 2013;74:1295-9. [PMID: 23777932 DOI: 10.1016/j.humimm.2013.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
208 Anglicheau D, Delville M, Lamarthee B. Non anti-HLA antibodies and acute rejection: A critical viewpoint. Nephrol Ther 2019;15 Suppl 1:S53-9. [PMID: 30981396 DOI: 10.1016/j.nephro.2019.03.003] [Reference Citation Analysis]
209 Cecka JM. Significance of histocompatibility in organ transplantation. Current Opinion in Organ Transplantation 2007;12:402-8. [DOI: 10.1097/mot.0b013e3281c55d8c] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
210 Cai J, Terasaki PI. Post-transplantation antibody monitoring and HLA antibody epitope identification. Current Opinion in Immunology 2008;20:602-6. [DOI: 10.1016/j.coi.2008.07.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
211 Terasaki PI. A personal perspective: 100-year history of the humoral theory of transplantation. Transplantation. 2012;93:751-756. [PMID: 22453870 DOI: 10.1097/tp.0b013e3182483713] [Cited by in Crossref: 55] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
212 Alheim M, Johansson SM, Hauzenberger D, Grufman P, Holgersson J. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells. Tissue Antigens. 2010;75:269-277. [PMID: 20070600 DOI: 10.1111/j.1399-0039.2009.01439.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
213 Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M. Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int 2010;23:858-9. [PMID: 20003031 DOI: 10.1111/j.1432-2277.2009.01022.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
214 Everly MJ, Terasaki PI. Monitoring and treating posttransplant human leukocyte antigen antibodies. Human Immunology 2009;70:655-9. [DOI: 10.1016/j.humimm.2009.04.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
215 Redfield RR, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011;23:685-691. [PMID: 21982511 DOI: 10.1016/j.coi.2011.07.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
216 Prendergast MB, Gaston RS. Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5:1305-1311. [PMID: 20448067 DOI: 10.2215/cjn.07241009] [Cited by in Crossref: 100] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
217 Ravindranath MH, Filippone EJ, Amato-Menker CJ, Arosa FA, Das B, Ou Y, Norin AJ. Antibodies to cryptic epitopes on HLA class I and class II heavy chains bound to single antigen beads: Clinically relevant? Transpl Immunol 2021;69:101482. [PMID: 34656784 DOI: 10.1016/j.trim.2021.101482] [Reference Citation Analysis]
218 Tait BD. Solid phase assays for HLA antibody detection in clinical transplantation. Current Opinion in Immunology 2009;21:573-7. [DOI: 10.1016/j.coi.2009.07.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
219 Nickerson P, Heeger PS. Proteomic Portrayal of Transplant Pathologies. JASN 2009;20:236-8. [DOI: 10.1681/asn.2008121243] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
220 Zhang Q, Reed EF. Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol. 2010;22:682-688. [PMID: 20833523 DOI: 10.1016/j.coi.2010.08.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
221 Sicard A, Chen CC, Morelon E, Thaunat O. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection. Curr Opin Organ Transplant 2016;21:368-74. [PMID: 27258579 DOI: 10.1097/MOT.0000000000000329] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
222 Katsuma A, Yamamoto I, Komatsuzaki Y, Niikura T, Kawabe M, Okabayashi Y, Yamakawa T, Katsumata H, Nakada Y, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation. Nephrology (Carlton) 2016;21 Suppl 1:31-4. [PMID: 26971538 DOI: 10.1111/nep.12772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
223 Hamdani G, Goebel JW, Brailey P, Portwood EA, Hooper DK, Girnita AL. IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients. Pediatr Transplantation 2018;22:e13219. [DOI: 10.1111/petr.13219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
224 Akgul S, Oğuz F, Çalışkan Y, Kekik Ç, Çağatay P, Türkmen A, Nane I, Aydın F, Temurhan S. The Effect of Anti-Human Leukocyte Antigen, Anti-Major Histocompatibility Complex Class 1 Chain-Related Antigen A, and Anti-Glutathione Transferase-T1 Antibodies on the Long-Term Survival of Renal Allograft. Transplantation Proceedings 2013;45:890-4. [DOI: 10.1016/j.transproceed.2013.02.097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Dumortier J, Dedic T, Erard-poinsot D, Rivet C, Guillaud O, Chambon-augoyard C, Bosch A, Lachaux A, Couchonnal E, Thaunat O, Boillot O, Dubois V. Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: “Liaisons dangereuses”? Transplant Immunology 2019;54:47-51. [DOI: 10.1016/j.trim.2019.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
226 Cooper JE, Gralla J, Klem P, Chan L, Wiseman AC. High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction. Transplantation 2014;97:1253-9. [PMID: 24937199 DOI: 10.1097/01.TP.0000443226.74584.03] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
227 Sutherland SM, Chen G, Sequeira FA, Lou CD, Alexander SR, Tyan DB. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2012;16:12-7. [PMID: 22093755 DOI: 10.1111/j.1399-3046.2011.01599.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 12.5] [Reference Citation Analysis]
228 Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin Exp Immunol 2017;189:158-70. [PMID: 28518214 DOI: 10.1111/cei.12988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
229 Tonnerre P, Gérard N, Chatelais M, Poli C, Allard S, Cury S, Bressollette C, Cesbron-Gautier A, Charreau B. MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol. 2013;24:954-966. [PMID: 23539759 DOI: 10.1681/asn.2012080814] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
230 Staeck A, Khadzhynov D, Kleinsteuber A, Lehner L, Duerr M, Budde K, Lachmann N, Halleck F, Staeck O. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients. Transpl Immunol 2020;63:101333. [PMID: 32919027 DOI: 10.1016/j.trim.2020.101333] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]